Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Meningioma 3Brain Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Radiation Injuries 2Pituitary Neoplasms 2Nerve Sheath Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Wilms Tumor 1Vascular Neoplasms 1Uterine Cervical Neoplasms 1Thymus Neoplasms 1Thymoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Clear Cell 1Resectable Lung Non-Small Cell Carcinoma 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neurofibrosarcoma 1Neuroblastoma 1Neurilemmoma 1Neoplasms, Adipose Tissue 1Nasopharyngeal Carcinoma 1Myoepithelioma 1Mesothelioma, Malignant 1

Interventions

Specimen Handling 2nedaplatin 1X-Rays 1Relaxation Therapy 1Protons 1Proton Therapy 1Platinum Compounds 1Physical Therapy Modalities 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Resectable Lung Non-Small Cell Carcinoma × Proton Therapy × Clear all
NCT06008730 2025-11-10

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Emory University

Phase 2 Recruiting
20 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡